Screener
Intellia Therapeutics NTLA Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's invested capital?
- Intellia Therapeutics (NTLA) reported invested capital of $694.99M in Q2 2026.
- How has Intellia Therapeutics's invested capital changed year-over-year?
- Intellia Therapeutics's invested capital increased by 190.4% year-over-year, from -$768.84M to $694.99M.
- What is the long-term trend for Intellia Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Intellia Therapeutics's invested capital has grown at a 8.4% compound annual growth rate (CAGR), from $406.36M to $609.26M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Intellia Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude